| # | Drug | Count |
|---|---|---|
| 0 | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | 32 |
| 1 | ACETAMINOPHEN | 21 |
| 2 | CEFTRIAXONE SODIUM | 17 |
| 3 | APIXABAN | 16 |
| 4 | PACLITAXEL | 16 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 16 |
| 6 | ACETAMINOPHEN 500MG | 15 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 15 |
| 8 | CEFTRIAXONE | 15 |
| 9 | PAIN RELIEVER | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOXERCALCIFEROL | 1 | 0.0060 |
| 1 | CROTALIDAE IMMUNE F(AB)2(EQUINE) | 1 | 0.0053 |
| 2 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 3 | OVINE DIGOXIN IMMUNE FAB | 1 | 0.0048 |
| 4 | COSYNTROPIN | 1 | 0.0045 |
| 5 | 1169 HYDROGEN PEROXIDE SPRAY | 1 | 0.0032 |
| 6 | HYDROGEN PEROXIDE | 1 | 0.0030 |
| 7 | FERRIC DERISOMALTOSE | 4 | 0.0029 |
| 8 | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | 32 | 0.0029 |
| 9 | FERUMOXYTOL | 5 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Contrast Agent for Ultrasound Imaging [EPC] | 26 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 2 | Corticosteroid [EPC] | 22 |
| 3 | Microtubule Inhibitor [EPC] | 18 |
| 4 | Benzodiazepine [EPC] | 17 |
| 5 | Factor Xa Inhibitor [EPC] | 17 |
| 6 | Opioid Agonist [EPC] | 17 |
| 7 | Parenteral Iron Replacement [EPC] | 16 |
| 8 | Loop Diuretic [EPC] | 14 |
| 9 | Platinum-based Drug [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Contrast Agent for Ultrasound Imaging [EPC] | 26 | 0.0044 |
| 1 | Parenteral Iron Replacement [EPC] | 16 | 0.0012 |
| 2 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 3 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 4 | Uric Acid-specific Enzyme [EPC] | 3 | 0.0008 |
| 5 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 6 | Radiographic Contrast Agent [EPC] | 13 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |